Diffinity Genomics acquired by Chiral Technologies. Read more...
Diffinity Genomics issued patent for their technology "Spatially inhomogenously functionalized porous media and method for use in selective removal of contaminants". The patent was issued June 23, 2015.
Diffinity strives to give its customers best possible solution for their nucleic acid purification needs. We believe that alliances are the best mechanism for achieving these goals.
Diffinity’s partner program capitalizes on the synergy arising out of alliances. It ensures the engagement of partners at every stage – from scientific research to value generation, ultimately helping us to serve our customers better.